^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    SureSeq™ Myeloid Plus Panel

    Company:
    Sysmex Corp
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    The SureSeq Myeloid Plus Panel accurately detects SNVs and indels in genes such as CEBPA, JAK2, CALR and MPL, as well as structural variants including FLT3-ITDs and KMT2A-PTDs, and is able to detect low-frequency SNVs and indels with confidence.
    Cancer:
    Acute Myelogenous Leukemia, Chronic Myeloid Leukemia
    Gene:
    CALR (Calreticulin), CEBPA (CCAAT Enhancer Binding Protein Alpha), FLT3 (Fms-related tyrosine kinase 3), JAK2 (Janus kinase 2), KMT2A (Lysine Methyltransferase 2A), MPL (MPL Proto-Oncogene, Thrombopoietin Receptor)
    Method:
    Next-Generation Sequencing (NGS)